Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002233015 | SCV001730283 | benign | Chondrodysplasia punctata, brachytelephalangic, autosomal | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000952067 | SCV004164143 | likely benign | not provided | 2023-02-01 | criteria provided, single submitter | clinical testing | ARSL: BS2 |
Ambry Genetics | RCV004025034 | SCV004908680 | likely benign | Inborn genetic diseases | 2022-01-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Diagnostic Laboratory, |
RCV000606976 | SCV000734778 | likely benign | X-linked chondrodysplasia punctata 1 | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000952067 | SCV001963977 | likely benign | not provided | no assertion criteria provided | clinical testing |